[1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) Dichloride>95.0%(T)5g

1-Boc-5-Fluorospiro[indoline-3,4'-piperidine], 95.0%, 100mg

5-(BENZYLOXYMETHYL)-7-BROMO-4-METHOXY-5H-PYRROLO[3,2-D]PYRIMIDINE, 95.0%, 10g

Zenrifugenflaschen aus PPCO, mit Dichtungsverschluss, Vol. 500 ml, 4 Stück

(S)-N-(2-(4-Cyclohexyl-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 250mg

Ethyl 3-methoxy-2-oxo-1,2-dihydropyridine-4-carboxylate, 97%, 250mg

1-[2-(Trifluoromethyl)phenyl]-1H-imidazole-5-carboxylic acid, 1g

4,4,4-Trifluoro-2-methylbutan-2-amine, 98.0%, 250mg

2-(2-Acetamidophenoxy)acetic acid, 97%, 5g

2-Ethylthiophene, 98.0%, 5g

1-(2-Fluoro-5-methylpyridin-3-yl)ethanone, 95+%, 1g

(4aR,5R,6S)-4a-Hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3H)-one, 97%, 100mg

METHYL 2-CYCLOPROPYLOXAZOLE-4-CARBOXYLATE, 95.0%, 500mg